Previous gene expression screening suggested estrogen receptor expression may be increased by FZD9 loss and alterations in estrogen receptors have been associated with lung cancer, so we measured expression of estrogen receptor α (ESR1) and β (ESR2) (19). The gene discussed is ESR1; the disease is lung carcinoma.